[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation–meta-analysis–
Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have been developed as
alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for …
alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
[HTML][HTML] Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: a view …
AS Hersi, YS Alhebaishi, O Hamoui, T Hassan… - Journal of the Saudi …, 2018 - Elsevier
Clinical guidelines for the prevention of stroke in patients with nonvalvular atrial fibrillation
(NVAF) are available from several international cardiology associations. Patients with NVAF …
(NVAF) are available from several international cardiology associations. Patients with NVAF …
Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis
KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular …
Background The global real-life impact of non-vitamin K antagonist oral anticoagulants
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
Real‐World Comparative Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country
P Mitsuntisuk, S Nathisuwan… - Clinical …, 2021 - Wiley Online Library
We aimed to compare effectiveness and safety of the non‐vitamin K antagonist oral
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
Non-vitamin K antagonist oral anticoagulants in secondary stroke prevention in atrial fibrillation patients: an updated analysis by adding observational studies
Background This meta-analysis aimed to evaluate the efficacy and safety of non-vitamin K
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in secondary …
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in secondary …
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
Z Xue, H Zhang - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Several randomized trials and real-world studies have reported
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
[HTML][HTML] NOACs vs. warfarin for stroke prevention in nonvalvular atrial fibrillation
P Patel, J Pandya, M Goldberg - Cureus, 2017 - ncbi.nlm.nih.gov
Atrial fibrillation is a heart arrhythmia associated with increased risk for ischemic stroke.
Vitamin K antagonists were developed to decrease a patient's clotting risk; however, these …
Vitamin K antagonists were developed to decrease a patient's clotting risk; however, these …